GRDX

GridAI Technologies Corp. Common Stock (GRDX)

Stock · NASDAQ · Health Care

$4.18as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 9, 2026

GRDX Included in 12 Health Care Stocks Moving Thursday. GRDX was among 12 health care stocks that saw movement during Thursday's intraday session. The stock is currently trading near the upper end of its 52‑week range and is above the 70.4 RSI, indicating a high level of buying interest. It has touched its support level of $2.03 nine times, showing a key area to watch.

Active signals

Support level
$2.1
Industry
Biotechnology: Pharmaceutical Preparations

What GRDX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike30-5.8%37%
Bollinger Band Breakdown23-21.1%30%
Bollinger Band Breakout19-17.3%37%
200-Day Moving Average TouchActive now4-7.4%25%
Any 20-session window (baseline)-14.0%33%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About GRDX

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kin…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

1-day range
$4.15$4.75
Market cap
$19.91M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-5.31
Dividend yield
—
Beta
1.72
Avg. volume
106.2K
52-week range
$1.87$6.93

How GridAI Technologies Corp. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$36.3KSG&A$5.50M (15173%)R&D$925.5K (2553%)Cost of Revenue$693.7K (1914%)GRDX

Source: 10-K filed May 1, 2026 · via SEC EDGAR / Finnhub

Gross Profit-$657.4K(-1814%)
Operating Income-$7.08M(-19540%)

GridAI Technologies Corp. Common Stock Competitors

Chosen by industry and closest market cap.

  • GRDX
    GridAI Technologies Corp. Common Stock
    $4.22
    ▼ 5.38%
    Market cap $19.91MP/E —
    $1.87$6.93
  • DARE
    Dare Bioscience Inc. Common Stock
    $0.725
    ▼ 2.03%
    Market cap $19.92MP/E —
    $0.69$3.78
  • CELU
    Celularity Inc. Class A Common Stock
    $1.25
    ▼ 6.02%
    Market cap $19.77MP/E —
    $0.5601$2.55
  • RKTO
    Rocket One Inc. Common Stock
    $0.507
    ▼ 5.59%
    Market cap $19.75MP/E —
    $0.51$2.45
  • CLRB
    Cellectar Biosciences Inc. Common Stock
    $1.14
    ▼ 4.20%
    Market cap $20.14MP/E —
    $1.15$5.07
  • NXTC
    NextCure Inc. Common Stock
    $6.24
    ▼ 9.30%
    Market cap $20.19MP/E —
    $1.55$15.74
  • HOWL
    Werewolf Therapeutics Inc. Common Stock
    $0.98
    ▼ 1.71%
    Market cap $19.58MP/E —
    $0.27$2.24

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
500.0K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
332.2K
Total value held
$671.1K
Institutional holders
13
Top holders this quarter
  • Unknown183.8K
  • Unknown47.8K
  • Unknown33.3K
  • Unknown23.4K
  • Unknown18.3K
  • Unknown12.7K
  • Unknown8.0K
  • Unknown3.2K
  • Unknown1.3K
  • Unknown504

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.